n.torrence
TL3 Regular · Split, HR
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 2 August 2024 · last posted 3d · groups: regional-na
123 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #98 · Analytics › COA interpretation · 25 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #65 · Practice › Interactions · 24 Jul 2026 · 5 likes On post #61 — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Follow-up: Reading an interaction checker output critically Replied, post #63 · Practice › Interactions · 24 Jul 2026 · 7 likes On post #59 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
How shortages have affected compounding permissions Replied, post #50 · Access › Shortages · 19 Jul 2026 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #98 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour…
-
Tracking a shortage from primary sources rather than rumour Replied, post #100 · Access › Shortages · 13 Jul 2026 · 21 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
A revision dispute resolved on the topic rather than in the history Replied, post #13 · Meta › Wiki maintenance · 12 Jul 2026 · 7 likes This follows post #10 rather than contradicting it. Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #30 · Evidence › Journal club · 6 Jul 2026 · 4 likes On post #26 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
An 18-month record including the parts that went badly Replied, post #59 · Outcomes › Progress reports · 4 Jul 2026 · 1 like This follows post #56 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #37 · Pharmacology › Formulation chemistry · 4 Jul 2026 · 22 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Documenting a supplier's response to a discrepancy Replied, post #24 · Sourcing › Vendor reports · 27 Jun 2026 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Naming conventions for research peptides and the confusion they cause Replied, post #21 · Compounds › Other compounds · 26 Jun 2026 · 18 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #70 · Meta › Announcements · 24 Jun 2026 · 2 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Packaging that arrived damaged: documenting it properly Replied, post #29 · Sourcing › Logistics · 22 Jun 2026 · 2 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Historical amylin analogues and what happened to them Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2026 · 18 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Retatrutide mass and identity: what a report should show Started this topic · Compounds › Retatrutide · 18 Jun 2026 · 21 likes Posting this under the heading it deserves: Retatrutide mass and identity: what a report should show Everything below is what sits behind that. Comparing SURMOUNT-4 (…
-
Prescription portability between countries Replied, post #66 · Access › International · 16 Jun 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Documenting a supplier's response to a discrepancy Replied, post #11 · Sourcing › Vendor reports · 8 Jun 2026 · 20 likes Worth separating two things that post #7 runs together. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #76 · Sourcing › Red flags · 5 Jun 2026 · 6 likes Coming back to post #74, because the follow-up matters more than the original answer. Inability to trace lots: if you ask "where was this synthesised, by whom, under…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #51 · Compounds › Semaglutide · 4 Jun 2026 · 0 likes Coming back to post #49, because the follow-up matters more than the original answer. On alcohol: the labelling does not contraindicate it, but it raises gastric…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #59 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 5 likes Worth separating two things that post #55 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Reading a trial's population section before its results Replied, post #43 · Evidence › Trials · 22 May 2026 · 1 like Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Why the timeline is on the right and not the left — what changed since Replied, post #35 · Meta › Site feedback · 12 May 2026 · 3 likes This follows post #32 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #18 · Practice › Storage & stability · 7 May 2026 · 1 like Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #12 · Analytics › Impurities & related substances · 6 May 2026 · 13 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #32 · Practice › Reconstitution · 2 May 2026 · 25 likes I read post #30 twice before replying, because I had assumed the opposite. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most…
-
Request: show the solution author in the topic list — what changed since Replied, post #5 · Meta › Feature requests · 30 Apr 2026 · 10 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
Batch numbers that do not match the vial label Replied, post #10 · Sourcing › Red flags · 28 Apr 2026 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #2 · Compounds › Semaglutide · 13 Apr 2026 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #36 · Evidence › Journal club · 11 Apr 2026 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Grapefruit: why this class is not the class that cares Replied, post #135 · Practice › Interactions · 8 Apr 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: is percentage weight change the right endpoint? Replied, post #26 · Evidence › Journal club · 30 Mar 2026 · 2 likes post #25 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #17 · Evidence › Preprints · 25 Mar 2026 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #53 · Practice › Reconstitution · 23 Mar 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Grapefruit: why this class is not the class that cares Replied, post #60 · Practice › Interactions · 20 Mar 2026 · 17 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #101 · Lounge › Introductions · 18 Mar 2026 · 10 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #7 · Evidence › Journal club · 11 Mar 2026 · 5 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #19 · Start Here › Welcome · 1 Mar 2026 · 2 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #20 · Outcomes › Body composition · 28 Feb 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #51 · Analytics › Mass spectrometry · 27 Feb 2026 · 22 likes Worth separating two things that post #47 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #47 · Start Here › Welcome · 27 Feb 2026 · 5 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Dead volume across syringe and needle combinations Replied, post #73 · Devices › Syringes & needles · 16 Feb 2026 · 18 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #50 · Outcomes › Progress reports · 13 Feb 2026 · 25 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Adolescents: a distinct evidence base — one year on Replied, post #64 · Clinical › Special populations · 13 Feb 2026 · 2 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #68 · Sourcing › Vendor reports · 11 Feb 2026 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #43 · Data & Tools › Calculators · 9 Feb 2026 · 7 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #46 · Analytics › Method validation · 5 Feb 2026 · 1 like Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Revisiting: Absolute versus relative contraindications Replied, post #10 · Safety › Contraindications · 18 Jan 2026 · 0 likes This follows post #7 rather than contradicting it. Severe renal impairment (eGFR
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #18 · Practice › Side effects · 14 Jan 2026 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Nausea: the most common side effect and the most dose- and titration-dependent one. It is…
-
The headache that turns out to be dehydration Replied, post #101 · Nutrition & Training › Hydration & electrolytes · 19 Dec 2025 · 1 like Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #66 · Practice › Interactions · 10 Dec 2025 · 4 likes Coming back to post #64, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #21 · Compounds › Retatrutide · 9 Dec 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Prescription requirements and telehealth models Replied, post #43 · Sourcing › Regulatory · 2 Dec 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
When to stop reading forums, including this one Replied, post #56 · Wellbeing › Mental health · 1 Dec 2025 · 26 likes On post #52 — agreed on the reasoning, with one qualification. Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #101 · Sourcing › Vendor reports · 30 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Thyroid function tests during substantial weight change Replied, post #139 · Clinical › Bloodwork · 18 Nov 2025 · 14 likes post #138 answers the question as asked. The question underneath it is different. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
-
Tracking that stops updating and then resumes Replied, post #46 · Sourcing › Logistics · 15 Nov 2025 · 1 like Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Reading SURMOUNT-1 without the press release Replied, post #64 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
New subcategory: rationale and scope Replied, post #107 · Meta › Announcements · 24 Oct 2025 · 12 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Payment mechanics and the recovery options that do not exist Replied, post #48 · Sourcing › Payments · 21 Oct 2025 · 2 likes post #47 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Splitting an overlong document into two Replied, post #41 · Documentation › Wiki requests · 15 Oct 2025 · 25 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #12 · Compounds › Tirzepatide · 12 Oct 2025 · 1 like post #11 is right about the mechanism and I think understates the practical bit. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #2 · Start Here › Welcome · 11 Oct 2025 · 17 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Research-use-only labelling: what it means and what it does not Replied, post #40 · Sourcing › Regulatory · 1 Oct 2025 · 33 likes post #39 is right about the mechanism and I think understates the practical bit. Import restrictions vary by compound and by jurisdiction: what is a controlled…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #45 · Pharmacology › Receptor biology · 28 Sep 2025 · 22 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Which panel is worth repeating and which is worth ignoring Replied, post #120 · Clinical › Bloodwork · 25 Sep 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Payment method and the leverage it gives you, ranked Replied, post #47 · Sourcing › Payments · 21 Sep 2025 · 3 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #3 · Practice › Dosing & titration · 15 Sep 2025 · 29 likes post #2 is right about the mechanism and I think understates the practical bit. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Documenting an adverse event properly Started this topic · Safety › Adverse events · 8 Sep 2025 · 0 likes On the subject in the title: Documenting an adverse event properly Working notes rather than a conclusion. General question, not a request for advice about my own care…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #117 · Compounds › Tirzepatide · 2 Sep 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #19 · Compounds › Tirzepatide · 26 Aug 2025 · 2 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #33 · Practice › Storage & stability · 22 Aug 2025 · 0 likes This follows post #30 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #10 · Compounds › Other compounds · 22 Aug 2025 · 8 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Gauge and length selection for subcutaneous injection Replied, post #21 · Devices › Syringes & needles · 17 Aug 2025 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
When a preprint is the best available evidence and we say so Replied, post #26 · Evidence › Preprints · 5 Aug 2025 · 28 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #31 · Compounds › Secretagogues & GH axis · 3 Aug 2025 · 15 likes post #30 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #35 · Practice › Reconstitution · 2 Aug 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
How to research a compound with no human data without deceiving yourself Replied, post #43 · Compounds › Other compounds · 1 Aug 2025 · 5 likes post #42 is right about the mechanism and I think understates the practical bit. Naming conventions for research peptides cause confusion because suppliers do not…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #20 · Analytics › HPLC & UHPLC · 28 Jul 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Asking about a compound your prescriber has not heard of Replied, post #106 · Clinical › Prescriber conversations · 26 Jul 2025 · 12 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
An emergency department visit, described afterwards Replied, post #46 · Safety › Adverse events · 25 Jul 2025 · 3 likes Picking up post #43: that is the part I would want checked first. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention…
-
Interpreting a composition change that is within the error bars Replied, post #21 · Outcomes › Body composition · 25 Jul 2025 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Comparing my trajectory with the trial curves, carefully Replied, post #26 · Outcomes › Progress reports · 20 Jul 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #71 · Compounds › Semaglutide · 15 Jul 2025 · 0 likes Picking up post #68: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #8 · Practice › Dosing & titration · 4 Jul 2025 · 0 likes Worth separating two things that post #4 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Repeatability versus intermediate precision Replied, post #105 · Analytics › Method validation · 30 Jun 2025 · 0 likes This follows post #102 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2025 · 17 likes Picking up post #30: that is the part I would want checked first. What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is…
-
Pre-registering a personal experiment, seriously Replied, post #108 · Research Methods › N-of-1 designs · 3 Jun 2025 · 2 likes On post #104 — agreed on the reasoning, with one qualification. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores)…
-
Pre-registering a personal experiment, seriously Replied, post #98 · Research Methods › N-of-1 designs · 3 Jun 2025 · 11 likes On post #94 — agreed on the reasoning, with one qualification. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1…
-
Pre-registering a personal experiment, seriously Replied, post #87 · Research Methods › N-of-1 designs · 2 Jun 2025 · 3 likes Coming back to post #85, because the follow-up matters more than the original answer. Confounding in personal experiments: other things change when you start a…
-
Half-life, steady state, and accumulation worked through Replied, post #51 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 12 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Pre-registering a personal experiment, seriously Replied, post #64 · Research Methods › N-of-1 designs · 31 May 2025 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #9 · Sourcing › Independent verification · 24 Apr 2025 · 19 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #86 · Evidence › Journal club · 21 Apr 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Requesting a page: what makes a good request Replied, post #46 · Documentation › Wiki requests · 5 Apr 2025 · 6 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Checking someone else's arithmetic: a worked example thread Replied, post #35 · Practice › Reconstitution · 3 Apr 2025 · 9 likes This follows post #32 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #45 · Sourcing › Vendor reports · 1 Apr 2025 · 12 likes I read post #43 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #36 · Practice › Reconstitution · 22 Mar 2025 · 8 likes post #35 is right about the mechanism and I think understates the practical bit. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #92 · Analytics › COA interpretation · 17 Mar 2025 · 0 likes post #91 answers the question as asked. The question underneath it is different. What fields matter on a certificate: lot number matching the vial, test date, the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #73 · Analytics › COA interpretation · 12 Mar 2025 · 4 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Preservatives: function, testing, and limits Replied, post #19 · Pharmacology › Formulation chemistry · 12 Mar 2025 · 22 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #7 · marked as the solution · Access › Insurance & coverage · 8 Mar 2025 · 24 likes post #6 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Deamidation and the close-eluting pair it produces Replied, post #6 · Analytics › Impurities & related substances · 7 Mar 2025 · 3 likes post #5 answers the question as asked. The question underneath it is different. Dimer and higher-order multimers: two or more peptide molecules bonded together. They…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #22 · Compounds › Semaglutide · 26 Feb 2025 · 30 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #62 · Evidence › Journal club · 17 Feb 2025 · 5 likes post #61 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #92 · Data & Tools › Calculators · 16 Feb 2025 · 13 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Protein density versus volume when you cannot eat much Replied, post #56 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 6 likes post #55 answers the question as asked. The question underneath it is different. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but…
-
A page that has drifted out of date and needs a maintainer Replied, post #51 · Documentation › Wiki requests · 13 Jan 2025 · 15 likes On post #47 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Coming back to: When to suspect the method rather than the sample Replied, post #111 · Analytics › Method validation · 21 Dec 2024 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #85 · Practice › Side effects · 19 Dec 2024 · 9 likes I read post #83 twice before replying, because I had assumed the opposite. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #126 · Practice › Dosing & titration · 15 Dec 2024 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Coming back to: When to suspect the method rather than the sample Replied, post #37 · Analytics › Method validation · 7 Dec 2024 · 27 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Time to steady state after a dose increase Replied, post #121 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 2 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #7 · Evidence › Journal club · 27 Oct 2024 · 17 likes I read post #5 twice before replying, because I had assumed the opposite. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction…
-
Identical chromatograms across two different lots Replied, post #40 · Sourcing › Red flags · 23 Oct 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #29 · Clinical › Comorbidities · 13 Oct 2024 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
When "no data" is the complete and final answer Replied, post #2 · Compounds › Other compounds · 9 Oct 2024 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #142 · Nutrition & Training › Hydration & electrolytes · 8 Oct 2024 · 2 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Irish differences from the UK position Replied, post #14 · Regional › UK & Ireland · 29 Sep 2024 · 2 likes post #13 answers the question as asked. The question underneath it is different. Importing for personal use: importing a prescription-only medicine without a…
-
Correlation in a self-tracked dataset: what it can support Replied, post #42 · Research Methods › Statistics · 21 Aug 2024 · 18 likes post #41 answers the question as asked. The question underneath it is different. Confounding: a third variable explains an apparent association. In randomised data,…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 15 Aug 2024 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…